Spotlight Stories

  1. Synergistic COVID Therapy Development 5/3/2021

    From the outside, it may look as if Biophytis took a sharp turn from its focus on aging to address Covid. But look again.

  2. 180 Life Sciences: Deliberately Seeking Serendipity 4/1/2021

    At 180 Life Sciences, veterans of the old-pharma world are building a small bio enterprise focused evenly on scientific and market opportunities in the inflammation space.

  3. Canadian COVID Vax Comes Forward 3/1/2021

    Long before the Warp Speed race, vaccines were a global business more characterized by collaboration than competition. In concert with its national regulator, Health Canada, IMV, Inc. could make world history with its approach to COVID vaccination.

  4. RNA's Rousing New Adventure 2/1/2021

    Dicerna shows how the multitude of “co-opportunities” of COVID in the RNA space has further encouraged companies to exploit the unique attributes of those approaches well beyond dealing with the immediate viral threat.

  5. Going Public In Mid-Pandemic 1/4/2021

    Just as the COVID pandemic hit, Timber Pharma was planning on going public. But that wasn’t the only challenge the company faced in the months ahead.